lilly glp 1 drugs Novo, buoyed by fast-growing GLP-1 drug sales RO OFFERS ELI LILLY'S FOUNDAYO™,
Description
Understanding their distinct mechanisms, clinical evidence bases, and how genetic and biomarker data inform personalized treatment selection helps patients and providers make evidence-based decisions
In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo
These effects extend beyond weight loss, suggesting anti-inflammatory mechanisms with broad potential for managing chronic diseases.
Among the numerous metabolic effects of GLP-1 are the glucose-dependent stimulation of insulin secretion, decrease of gastric emptying, inhibition of ...
95% CI 0.35, 3.14)
